Join to View Full Profile
9500 Euclid AveBuilding U10Cleveland, OH 44195
Phone+1 216-444-8600
Fax+1 216-445-6259
Dr. Bermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
OH State Medical License 2003 - 2027
FL State Medical License 2024 - 2026
NY State Medical License 2024 - 2025
NV State Medical License 2012 - 2023
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Optical Coherence Tomography in Multiple Sclerosis Patients Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 1 citationsVolumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.Amy Kunchok, Moein Amin, Tatchaporn Ongphichetmetha, Mengke Du, Robert Bermel
Annals of Neurology. 2025-11-01 - Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factors.Farren Bs Briggs, Jiayue Yang, Karlo Toljan, Devon S Conway, Carrie M Hersh
Multiple Sclerosis. 2025-10-26 - AI-driven reclassification of multiple sclerosis progression.Habib Ganjgahi, Dieter A Häring, Piet Aarden, Gordon Graham, Yang Sun
Nature Medicine. 2025-10-01
Journal Articles
- Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients with Alzheimer's and Parkinson's DiseaseHubert Fernandez, Justis P Ehlers, Jagan A Pillai, Sunil K Srivastava, Robert Bermel, James B Leverenz, Investigative Ophthalmology and Visual Science
Authored Content
- Optical Coherence Tomography Outcomes from SPRINT-MS, a Multicenter, Randomized, Double-Blind Trial of Ibudilast in Progressive Multiple SclerosisOctober 2020
Press Mentions
Cleveland Clinic Neurologist Says Virtual Second Opinions Fill a Widening GapMay 27th, 2025- A Peek Inside a Transformative Care Space in Our New Neurological BuildingMay 23rd, 2025
- Higher-Dosed Ocrelizumab Associated with Less Disability AccrualMarch 27th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
